Stockscreener 앱 받기
20.63
0.15%
0.03
시간 외 거래:
20.62
-0.010
-0.05%
전일 마감가:
$20.60
열려 있는:
$20.67
하루 거래량:
7.43M
Relative Volume:
0.59
시가총액:
$72.35B
수익:
$36.74B
순이익/손실:
$7.89B
주가수익비율:
9.4733
EPS:
2.1777
순현금흐름:
$182.70B
1주 성능:
+1.58%
1개월 성능:
+5.47%
6개월 성능:
+31.07%
1년 성능:
+74.98%
1일 변동 폭
$20.42
$20.75
1주일 범위
$20.42
$20.82
52주 변동 폭
$11.47
$21.22
바클레이즈 Stock (BCS) Company Profile
BCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCS
Barclays Plc Adr
|
20.63 | 71.95B | 36.74B | 7.89B | 182.70B | 2.1777 |
|
JPM
Jpmorgan Chase Co
|
307.55 | 854.38B | 278.82B | 56.24B | 40.06B | 19.49 |
|
BAC
Bank Of America Corp
|
50.48 | 375.38B | 198.53B | 28.07B | 22.38B | 3.4147 |
|
WFC
Wells Fargo Co
|
80.50 | 259.06B | 123.22B | 20.76B | 6.16B | 5.8309 |
|
HSBC
Hsbc Holdings Plc Adr
|
70.83 | 246.13B | 142.78B | 18.74B | 105.99B | 4.9976 |
|
RY
Royal Bank Of Canada
|
146.42 | 207.60B | 96.89B | 13.73B | -34.72B | 9.4824 |
바클레이즈 Stock (BCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-04 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2024-10-08 | 개시 | Goldman | Buy |
| 2024-09-05 | 개시 | Kepler | Buy |
| 2024-05-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-26 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-08 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2023-05-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-12-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2022-12-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-03-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-01-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-07 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-09-30 | 업그레이드 | Redburn | Neutral → Buy |
| 2021-03-16 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-03-12 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-11-10 | 다운그레이드 | Investec | Buy → Hold |
| 2020-07-10 | 업그레이드 | Investec | Hold → Buy |
| 2020-03-03 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2020-02-11 | 재개 | Credit Suisse | Neutral |
| 2019-11-26 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2019-09-05 | 업그레이드 | Keefe Bruyette | Underperform → Mkt Perform |
| 2019-08-21 | 업그레이드 | Exane BNP Paribas | Underperform → Neutral |
| 2019-04-18 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-01 | 업그레이드 | Berenberg | Hold → Buy |
| 2018-06-19 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-04-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-03-29 | 업그레이드 | Investec | Hold → Buy |
| 2018-03-20 | 다운그레이드 | Investec | Buy → Hold |
| 2018-03-08 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-01-11 | 다운그레이드 | Keefe Bruyette | Mkt Perform → Underperform |
| 2018-01-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2017-12-15 | 다운그레이드 | Investec | Buy → Hold |
| 2017-11-20 | 업그레이드 | BofA/Merrill | Underperform → Buy |
| 2017-10-31 | 업그레이드 | Keefe Bruyette | Underperform → Mkt Perform |
| 2017-10-20 | 업그레이드 | Berenberg | Sell → Hold |
모두보기
바클레이즈 주식(BCS)의 최신 뉴스
Barclays files 2024 annual report with SEC - MSN
Case Updater: PCP v Barclays – Waiver of privilege | Latin America | Global law firm - Norton Rose Fulbright
SEC Fair Fund Opens $25+ Payment Claims for Barclays Investors During 2019-2022 Trading Period - Stock Titan
Bit Digital Announces Proposed Offering of $100 Million Convertible Notes - Benzinga
Barclays Sticks to Its Buy Rating for BP p.l.c. (BP) - The Globe and Mail
HSBC Vs. BCS: Which Foreign Bank Deserves A Spot In Your Portfolio? - Barchart.com
HSBC vs. BCS: Which Foreign Bank Deserves a Spot in Your Portfolio? - The Globe and Mail
3rd UPDATE: Barclays 1st Half Net Profit +10% On Invest Bank; Shares Up - ADVFN
Rhumbline Advisers Reduces Stock Position in Barclays PLC $BCS - Defense World
MacroGenics (NASDAQ:MGNX) Now Covered by Analysts at Barclays - Defense World
Janux Therapeutics (NASDAQ:JANX) Now Covered by Barclays - Defense World
C4 Therapeutics (NASDAQ:CCCC) Now Covered by Barclays - Defense World
Summit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at Barclays - Defense World
Ralph Lauren (NYSE:RL) Price Target Cut to $353.00 by Analysts at Barclays - Defense World
Merus (NASDAQ:MRUS) Now Covered by Barclays - Defense World
Protagonist Therapeutics (NASDAQ:PTGX) Now Covered by Analysts at Barclays - Defense World
Xencor (NASDAQ:XNCR) Now Covered by Analysts at Barclays - Defense World
Caxton Associates LLP Purchases New Stake in VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
Amundi Purchases Shares of 621,058 VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
Royal Bank of Canada Buys 1,705,324 Shares of VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
Barclays Touches 52-Week High: How to Approach the Stock Now? - The Globe and Mail
Fred Alger Management LLC Has $2.11 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Millennium Management LLC Sells 2,898,605 Shares of VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 68,562 Shares of VNET Group, Inc.Unsponsored ADR $VNET - MarketBeat
Focus Partners Wealth Increases Stock Holdings in Barclays PLC $BCS - Defense World
Ellsworth Advisors LLC Invests $703,000 in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Scientech Research LLC Increases Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Alliancebernstein L.P. Trims Stake in Shell PLC Unsponsored ADR $SHEL - MarketBeat
LINEAGE INVESTOR NOTICE: Investor Files Class Action Lawsuit Against Lineage, Inc. and Attorneys Announce Opportunity for Investors with Substantial Losses to Lead Securities Class Action LawsuitLINE - Ariva
Alyeska Investment Group L.P. Sells 1,709,335 Shares of Endava PLC Sponsored ADR $DAVA - MarketBeat
Shell PLC Unsponsored ADR $SHEL Shares Sold by Clark Capital Management Group Inc. - MarketBeat
Shell PLC Unsponsored ADR (NYSE:SHEL) Receives $76.71 Average PT from Brokerages - MarketBeat
Permanens Capital L.P. Buys 5,859 Shares of Shell PLC Unsponsored ADR $SHEL - MarketBeat
Banque Transatlantique SA Acquires Shares of 10,150 Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Amundi Makes New $5.09 Million Investment in VNET Group, Inc. – Unsponsored ADR $VNET - Defense World
Cubist Systematic Strategies LLC Sells 2,650 Shares of Bicycle Therapeutics PLC Sponsored ADR $BCYC - Defense World
Vident Advisory LLC Buys Shares of 155,504 Autolus Therapeutics PLC Sponsored ADR $AUTL - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Acquired by Cutter Capital Management LP - MarketBeat
Checkpoint Capital L.P. Buys Shares of 9,011 Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Cormorant Asset Management LP Lowers Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Genmab A/S Sponsored ADR $GMAB Shares Sold by Alliancebernstein L.P. - MarketBeat
Why Alibaba Stock Pumped Higher Today - The Globe and Mail
MAI Capital Management Has $52,000 Position in Autolus Therapeutics PLC Sponsored ADR $AUTL - MarketBeat
Shell PLC Unsponsored ADR $SHEL Shares Sold by Interval Partners LP - MarketBeat
Adage Capital Partners GP L.L.C. Has $63.39 Million Holdings in Shell PLC Unsponsored ADR $SHEL - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of "Buy" by Brokerages - MarketBeat
Cinctive Capital Management LP Has $1.97 Million Position in Shell PLC Unsponsored ADR $SHEL - MarketBeat
Shell PLC Unsponsored ADR $SHEL Shares Purchased by Curi RMB Capital LLC - MarketBeat
Royal Bank of Canada Lowers Stock Holdings in Shell PLC Unsponsored ADR $SHEL - MarketBeat
Ieq Capital LLC Has $2.25 Million Holdings in Shell PLC Unsponsored ADR $SHEL - MarketBeat
ADAR1 Capital Management LLC Raises Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
바클레이즈 (BCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.20%
자본화:
|
볼륨(24시간):